Clinical Trial Update: Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating Gemcitabine and nab-paclitaxel in combination with the TheraBionic P1 device for metastatic pancreatic adenocarcinoma. Recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemcitabine (Gemcitabine)
• TheraBionic P1 Device

Snippet

Sponsor: Barbara Ann Karmanos Cancer Institute | Conditions: Metastatic Pancreatic Adenocarcinoma | Phase 2 | Status: RECRUITING